Is Prothena Corporation PLC halal to invest in?

According to Musaffa's Shariah screening methodology, Prothena Corporation PLC (PRTA) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Prothena Corporation PLC a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Prothena Corporation PLC using these criteria to determine its compliance status.

Can Muslims buy shares of Prothena Corporation PLC?

Muslim investors may consider investing in Prothena Corporation PLC if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Prothena Corporation PLC classified as NOT HALAL?

Musaffa determines the Shariah status of Prothena Corporation PLC by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Prothena Corporation PLC updated?

The Shariah compliance status of Prothena Corporation PLC may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Prothena Corporation PLC become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Prothena Corporation PLC?

You can check the latest Shariah compliance status of Prothena Corporation PLC on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

PRTA Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: March 03, 2026

Report Source: 2025 Annual Report

Analyst's Ratings for Prothena Corporation PLC (PRTA)

Based on 13 analysts giving stock ratings to Prothena Corporation PLC in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Prothena Corporation PLC. Stock Analysis PRTA

United States Health Care Small Cap Report: 2025 Annual

Prothena Corp. Plc is a clinical-stage neuroscience company, which engages in the discovery and development of novel therapies to change the course of devastating diseases. The firm is engaged in protein dysregulation and a pipeline of investigational therapeutics for rare peripheral amyloid diseases. The firm is advancing a pipeline of therapeutic candidates for a range of indications and targets to integrate scientific insights around neurological dysfunction and the biology of misfolded proteins. The Company’s pipeline includes both wholly owned and partnered programs being developed for the potential treatment of diseases, including AL amyloidosis, ATTR amyloidosis, Alzheimer’s disease, Parkinson’s disease and a range of other neurodegenerative diseases. Its clinical programs include birtamimab for the potential treatment of AL amyloidosis, prasinezumab for the potential treatment of Parkinson’s disease, NNC6019/PRX004 for the potential treatment of ATTR amyloidosis, and PRX005 and PRX012 for the potential treatment of Alzheimer’s disease.

Key Statistics of Prothena Corporation PLC (PRTA)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$9.46$9.86

Today's Open

$9.73

Volume

700.06K

P/E Ratio (TTM)

52 Week Range

$4.32$11.80

Market Cap

602.39M

Avg. Volume

449.47K

Dividend Yield

Financial Metrics & Statements of Prothena Corporation PLC (PRTA)

FAQ's for Prothena Corporation PLC (PRTA)

According to Musaffa’s Shariah screening methodology, Prothena Corporation PLC (PRTA) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.